Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00950976 · ClinicalTrials.gov registry record · NA

Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients

A NA study of Nutritional Deficiency, sponsored by Société des Produits Nestlé (SPN).

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT00950976: Completed NA study of Nutritional Deficiency, sponsored by Société des Produits Nestlé (SPN).

NCT00950976 is a NA study of Nutritional Deficiency that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 14 participants, below the 126-participant average among 5 other Nutritional Deficiency trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00950976, a NA study of Nutritional Deficiency, has completed, sponsored by Société des Produits Nestlé (SPN).

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

To determine the level of citrulline to produce a given amount of arginine in healthy volunteers and surgical patients. Arginine-related amino acids are expected to increase as a result of increased substrate provided by citrulline.

Conditions Studied

Interventions

  • OTHER citrulline
  • OTHER Lemonade

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2008-03
Est. Completion 2010-08
Phase NA

What the finished NCT00950976 record still lists

NCT00950976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 126-participant average among 5 other Nutritional Deficiency trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Nutritional Deficiency appearing as the primary indexed condition, and to 2 interventions - of which citrulline is the first listed.

NCT00950976 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00950976 about?

NCT00950976 is a clinical study titled "Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients". To determine the level of citrulline to produce a given amount of arginine in healthy volunteers and surgical patients. Arginine-related amino acids are expected to increase as a result of increased substrate provided by citrulline.

What is the current status of trial NCT00950976?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2008-03. Estimated completion is 2010-08.

What conditions does trial NCT00950976 study?

This clinical trial studies the following conditions: Nutritional Deficiency.

What interventions are being tested in trial NCT00950976?

The interventions under investigation include: citrulline (OTHER), Lemonade (OTHER).

Who is sponsoring clinical trial NCT00950976?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00950976 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nutritional Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00950976, the US trial registry maintained by the National Library of Medicine. NCT00950976 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.